Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Ross Fiziol Zh 110(7): 11081127
These can include any of the following: Age: It is more common for people over age 65 to have kidney or liver issues, and this can affect how the medication is metabolized or processed in the body and how much of it becomes available to use
Zepbound (tirzepatide) is a once-weekly injectable medication approved by the FDA for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
If you would like to learn more, see full prescribing information here
Average responders (~60% of patients): Weight loss of 23 kg over 6 months, plateauing thereafter
US$ 21.02
US$ 28.83
US$ 23.26
US$ 23.06
US$ 25.21
US$ 24.47
US$ 27.58
US$ 20.32
US$ 26.93
US$ 22.27
US$ 23.67
